YTHDF2 and prostate carcinoma: This OTUB1‐YTHDF2‐PRSS8 axis downregulates nuclear β‐catenin via E‐cadherin, revealing a critical pathway in prostate cancer progression and identifying potential targets for therapeutic intervention.[154] Moreover, LINC00707 promotes HCC progression by enhancing cell proliferation, migration, and invasion.